Related Experiment Video
Updated: Jun 2, 2026

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
Published on: November 4, 2018
Liver transplantation for hereditary tyrosinemia type I: analysis of the UNOS database
Ronen Arnon1, Rachel Annunziato, Tamir Miloh
1Department of Pediatrics, Mount Sinai School of Medicine, New York, NY, USA. Ronen.arnon@mountsinai.org
Insights
Liver transplantation (LT) is a vital treatment for children with tyrosinemia type 1 (HT-1) experiencing liver failure. The study shows LT is effective, with survival rates of 90.4%, and its use has declined due to early diagnosis and treatment.
Area of Science:
- Hepatology
- Pediatric Gastroenterology
- Transplant Surgery
Background:
- Hereditary tyrosinemia type 1 (HT-1) can lead to progressive liver disease and hepatocellular carcinoma (HCC).
- Liver transplantation (LT) is a critical intervention for HT-1 patients with fulminant liver failure, HCC, or medically refractory decompensated chronic liver disease.
Purpose of the Study:
- To evaluate the indications for and outcomes of LT in children diagnosed with HT-1.
- To analyze trends in LT for HT-1 over a 20-year period.
Main Methods:
- Retrospective analysis of the UNOS database for pediatric patients with HT-1 who underwent LT between October 1987 and May 2008.
- Statistical comparison of transplant characteristics and survival rates.
Main Results:
- 125 (1.1%) of 11,467 pediatric patients in the UNOS database had HT-1 requiring LT.
- The mean age at LT increased significantly from the first decade (1.82 years) to the second decade (3.70 years) of the study (p=0.01).
- Overall one- and five-year patient survival rates post-LT were 90.4%.
Conclusions:
- LT remains a valuable option for children with HT-1 facing severe liver complications.
- The decreasing rate and increasing age at LT suggest improved early diagnosis and treatment with nitisinone (NTBC) have reduced the need for transplantation.
Abstract:
Patients with HT-1 can develop progressive liver disease and have a high incidence of HCC. LT is indicated in patients with fulminant liver failure, HCC or decompensated chronic liver disease refractory to NTBC. To determine the need for LT and outcomes after LT in children with HT-1. Children with HT-1 who had LT between 10/1987 and 5/2008 were identified from the UNOS database. Of 11,467 children in the UNOS database, 125 (1.1%) required LT secondary to HT-1. Mean age at LT was two and half yr (s.d. ± 3.6 yr). Mean age at LT during the first 10 yr of the study (1.82, s.d. ± 2.86 yr) was significantly lower than in the last decade (3.70, s.d. ± 4.42 yr), p = 0.01. Nearly half of the patients (58, 46.4%) were transplanted between 1988 and 1992. Overall, one- and five-yr patient survival was 90.4% and 90.4%, respectively. LT is a valuable option for children with HT-1 with fulminant liver failure or when medical treatment fails. The rate of LT for children with HT-1 has decreased and age at transplant increased over the last decade most probably reflecting the effect of early diagnosis and treatment with NTBC.
Related Concept Videos
Kidney Transplant I: Introduction
Jaundice
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Inborn Errors of Metabolism
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...

